Iconacy Orthopedic Implants gets FDA clearance on CIMA
Iconacy Orthopedic Implants, a privately held medical device company in Warsaw, IN, received FDA clearance to market their highly crosslinked UHMWPE prepared using the CIMA process developed at Cambridge Polymer Group and the Massachusetts General Hospital. CIMA is a patented highly crosslinked, low wear and oxidation-resistant ultra high molecular weight polyethylene that is non-exclusively licensed to Iconacy for use in their I-Hip total hip replacement technology.
Source: Stacy Page Online